Paradigm received a favorable Medicare determination by Cahaba Government Benefit Administrators, a contractor with the Centers for Medicare and Medicaid Services, for the post-decompression and motion preserving interlaminar stabilization device.
The Coflex received FDA PMA approval at the end of 2012, and reached a favorable Medicare determination for use as a non-fusion alternative for symptomatic spinal stenosis.
More Articles on Devices:
Drug-Device Combination Market to Reach $30.5B by 2017
InspireMD Names Alan Milinazzo President, CEO
Soft Tissue Regeneration Receives Market Approval for Rotator Cuff Repair Device
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.